Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30055939HIVENSG00000186951.17protein_codingPPARANoNo5465Q07869
TVIS30055940HIVENSG00000186951.17protein_codingPPARANoNo5465Q07869
TVIS30055941HIVENSG00000186951.17protein_codingPPARANoNo5465Q07869
TVIS20040704HPVENSG00000186951.17protein_codingPPARANoNo5465Q07869
TVIS44043072HTLV-1ENSG00000186951.17protein_codingPPARANoNo5465Q07869
TVIS44048213HTLV-1ENSG00000186951.17protein_codingPPARANoNo5465Q07869
TVIS44048233HTLV-1ENSG00000186951.17protein_codingPPARANoNo5465Q07869
TCGA Plot Options
Drug Information
GenePPARA
DrugBank IDDB11133
Drug NameOmega-3 fatty acids
Target IDBE0000071
UniProt IDQ07869
Regulation Typeactivator
PubMed IDs19585164; 24986106
CitationsRudkowska I, Garenc C, Couture P, Vohl MC: Omega-3 fatty acids regulate gene expression levels differently in subjects carrying the PPARalpha L162V polymorphism. Genes Nutr. 2009 Sep;4(3):199-205. doi: 10.1007/s12263-009-0129-2. Epub 2009 Jul 8.@@Liu M, Montgomery MK, Fiveash CE, Osborne B, Cooney GJ, Bell-Anderson K, Turner N: PPARalpha-independent actions of omega-3 PUFAs contribute to their beneficial effects on adiposity and glucose homeostasis. Sci Rep. 2014 Jul 2;4:5538. doi: 10.1038/srep05538.
GroupsApproved; Nutraceutical
Direct Classification
SMILES
Pathways
PharmGKB
ChEMBL